Cargando…

Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death

BACKGROUND: Stimulation of CD40 can augment anti-cancer T cell immune responses by triggering effective activation and maturation of antigen-presenting cells (APCs). Although CD40 agonists have clinical activity in humans, the associated systemic activation of the immune system triggers dose-limitin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunekreeft, Kim L, Strohm, Corinna, Gooden, Marloes J, Rybczynska, Anna A, Nijman, Hans W, Grigoleit, Götz U, Helfrich, Wijnand, Bremer, Edwin, Siegmund, Daniela, Wajant, Harald, de Bruyn, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022212/ https://www.ncbi.nlm.nih.gov/pubmed/24741998 http://dx.doi.org/10.1186/1476-4598-13-85

Ejemplares similares

Galectin-9 Activates and Expands Human T-Helper 1 Cells
por: Gooden, Marloes J. M., et al.
Publicado: (2013)

SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells
por: Müller-Sienerth, Nicole, et al.
Publicado: (2011)

CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
por: El-Mesery, M, et al.
Publicado: (2013)

Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo
por: de Bruyn, Marco, et al.
Publicado: (2010)

CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism
por: Medler, Juliane, et al.
Publicado: (2022)

The Ever-Expanding Immunomodulatory Role of Calreticulin in Cancer Immunity
por: de Bruyn, Marco, et al.
Publicado: (2015)

Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats
por: Wei, Yunwei, et al.
Publicado: (2010)

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
por: Komdeur, Fenne L., et al.
Publicado: (2016)

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
por: Bremer, Edwin, et al.
Publicado: (2008)

Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects
por: Eggleton, Paul, et al.
Publicado: (2011)

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
por: Hendriks, Djoke, et al.
Publicado: (2016)

TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
por: Wajant, Harald, et al.
Publicado: (2019)

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
por: Wiersma, Valerie R, et al.
Publicado: (2012)

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism
por: Nelke, Johannes, et al.
Publicado: (2020)

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
por: He, Yuan, et al.
Publicado: (2017)

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
por: Lang, Isabell, et al.
Publicado: (2022)

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2018)

TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer
por: Siegmund, Daniela, et al.
Publicado: (2022)

Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
por: Siegmund, Daniela, et al.
Publicado: (2023)

The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux
por: Wiersma, Valerie R, et al.
Publicado: (2015)

Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
por: Siegmund, Daniela, et al.
Publicado: (2016)

Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling
por: Füllsack, Simone, et al.
Publicado: (2019)

Applications of Anti-Cytomegalovirus T Cells for Cancer (Immuno)Therapy
por: Britsch, Isabel, et al.
Publicado: (2023)

TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling
por: Kreckel, Jennifer, et al.
Publicado: (2019)

CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants
por: Trebing, J, et al.
Publicado: (2014)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
por: Koopmans, Iris, et al.
Publicado: (2018)

TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
por: Rauert, H, et al.
Publicado: (2011)

Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer
por: Wajant, Harald, et al.
Publicado: (2019)

The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2013)

Membrane lymphotoxin-α(2)β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist
por: Kucka, Kirstin, et al.
Publicado: (2021)

Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model
por: Munawar, Umair, et al.
Publicado: (2019)

The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1(+) subgroup of multiple myeloma cells for TNF-induced cell death
por: El-Mesery, Mohamed, et al.
Publicado: (2019)

TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
por: Carmona Arana, José Antonio, et al.
Publicado: (2014)

Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation
por: Luber, Verena, et al.
Publicado: (2020)

Soluble TNF-like weak inducer of apoptosis (TWEAK) enhances poly(I:C)-induced RIPK1-mediated necroptosis
por: Anany, Mohamed A., et al.
Publicado: (2018)

Case report: subacute tetraplegia in an immunocompromised patient
por: Zeller, Daniel, et al.
Publicado: (2017)

A novel function of CD40: induction of cell death in transformed cells
Publicado: (1996)

Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
por: Wajant, Harald
Publicado: (2019)

Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival
por: Vlaming, Martijn, et al.
Publicado: (2022)

Cancer induction by restriction of oncogene expression to the stem cell compartment
por: Pérez-Caro, María, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ucb97ajt976s99h46cdcl9rat3